DADC
ABMD

D.A. Davidson & Co’s Abiomed Inc ABMD Stock Holding History

D.A. Davidson & Co’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-837
Closed -$218K – 1037
2019
Q2 		$218K Sell
837
-451
-35% -$120K ﹤0.01% 878
2019
Q1 		$386K Buy
1,288
+82
+7% +$27.3K 0.01% 769
2018
Q4 		$392K Hold
1,206
– – 0.01% 721
2018
Q3 		$542K Sell
1,206
-82
-6% -$32.3K 0.01% 687
2018
Q2 		$527K Buy
1,288
+321
+33% +$116K 0.01% 684
2018
Q1 		$281K Buy
+967
New +$245K 0.01% 882
2017
Q3 		– Sell
-300
Closed -$42K – 2110
2017
Q2 		$42K Sell
300
-100
-25% -$13.4K ﹤0.01% 1594
2017
Q1 		$50K Hold
400
– – ﹤0.01% 1527
2016
Q4 		$45K Buy
+400
New +$46.3K ﹤0.01% 1640
2016
Q3 		– Sell
-619
Closed -$67K – 2507
2016
Q2 		$67K Hold
619
– – ﹤0.01% 1295
2016
Q1 		$58K Buy
619
+130
+27% +$11K ﹤0.01% 1335
2015
Q4 		$44K Buy
489
+439
+878% +$37.3K ﹤0.01% 1453
2015
Q3 		$4K Buy
+50
New +$4.41K ﹤0.01% 2043

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

D.A. Davidson & Co's ABMD Position: Q3 2019 in Review

D.A. Davidson & Co sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 837 shares — an estimated $218K sold.

D.A. Davidson & Co first reported a position in ABMD in Q3 2015 and held it in 13 quarters. The position peaked at $542K in Q3 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • D.A. Davidson & Co reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • D.A. Davidson & Co sold 837 Abiomed Inc shares in Q3 2019, an estimated $218K.
  • D.A. Davidson & Co first reported a position in Abiomed Inc in Q3 2015 and held it in 13 quarters.
  • D.A. Davidson & Co's Abiomed Inc position peaked at $542K in Q3 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on D.A. Davidson & Co's 13F filing for Q3 2019, filed 5 Nov 2019.